_________________________________________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-31553 | --- | --- | |------------------------------------------------------------------------------------------------------------------|--------------------------------------| | DOCUMENTS INC ...

CME Group Inc. (NASDAQ:CME) Q4 2022 Earnings Conference Call February 8, 2023 8:30 AM ET Company Participants Adam Minick - Investor Relations Terrence Duffy - Chairman and Chief Executive Officer Sean Tully - Senior Managing Director and Global Head, Rates & OTC Products Tim McCourt - Senior Managing Director and Global Head, Equity & FX Products Derek Sammann - Senior Managing Director and Global Head, Commodities, Options & International Markets Julie Winkler - Chief Commercial Officer John Pietrowicz - ...

• SOFR and Treasury options were added into CME Group's Portfolio Margining with OTC Swaps on December 12, 2022. Client average daily savings were $8.4 billion in 4Q22 • December SOFR futures RPC is closely approaching legacy Eurodollar futures RPC With significant rally of the U.S. dollar throughout most of 2022, and varying pace of global central bank policies causing interest rate differentials, the global foreign exchange market is in a highervolatility environment and CME Group FX ADV has come alive in ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________ FORM 10-Q _________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission fi ...

CME Group, Inc. (NASDAQ:CME) Q3 2022 Earnings Conference Call October 26, 2022 8:30 AM ET Company Participants John Peschier - MD, IR Terrence Duffy - Chairman & CEO Sean Tully - Senior MD and Global Head, Rates & OTC Products Tim McCourt - Senior MD & Global Head, Equity & FX Products Derek Sammann - Senior MD and Global Head, Commodities, Options & International Markets John Pietrowicz - CFO Julie Winkler - Senior MD & Chief Commercial Officer Sunil Cutinho - Chief Information Officer Conference Call Part ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________ FORM 10-Q _________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file nu ...

CME Group Inc. (NASDAQ:CME) Q2 2022 Earnings Conference Call July 27, 2022 8:30 AM ET Company Participants John Peschier - Investor Relations Terry Duffy - Chairman & Chief Executive Officer John Pietrowicz - Chief Financial Officer Lynne Fitzpatrick - Senior Managing Director & Deputy Chief Financial Officer Sean Tully - Senior Managing Director, Financial and OTC Products Derek Sammann - Senior Managing Director, Commodity & Options Products Julie Winkler - Chief Commercial Officer Sunil Cutinho - Preside ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________ FORM 10-Q _________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 - OR - ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file n ...

CME Group Inc. (NASDAQ:CME) Q1 2022 Earnings Conference Call April 27, 2022 8:30 AM ET Company Participants John Peschier – Managing Director-Investor Relations Terry Duffy – Chairman and Chief Executive Officer John Pietrowicz – Chief Financial Officer Julie Winkler – Chief Commercial Officer Sunil Cutinho – Chief Information Officer Derek Sammann – Senior Managing Director, Global Head-Commodities, Options and International Sean Tully – Senior Managing Director, Global Head-Rates and OTC Products Confere ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________ FORM 10-K _________________________________________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ChicagoIllinois | --- | --- | |-----------------------|-------| | | | | | | | ...